KEAP1 and polycystic ovary syndrome: This study aims to explore whether MT activates the Keap1–Nrf2 pathway through autophagy, thereby reducing the level of hepatic OS in PCOS, eventually paving new avenues and perspectives for investigating liver diseases associated with PCOS.